You have no items in your shopping cart.
You have no items in your shopping cart.
Catalog Number | orb1905844 |
---|---|
Category | Antibodies |
Description | Emicizumab(ACE 910) is a bispecific monoclonal antibody that bridges activated factor IX and activated factor X to mimic the function of activated factor VIII. Emicizumab is used for the prevention and treatment of hemophilia A. |
Clonality | Monoclonal |
CAS Number | 1610943-06-0 |
Concentration | 4.67 mg/mL |
Purity | 95.9% (SEC-HPLC) |
Conjugation | Unconjugated |
MW | 145.14 kDa |
Target | Emicizumab |
Biological Activity | Emicizumab(ACE 910) is a humanized monoclonal antibody that bridges activated factor IX and activated factor X to mimic the function of activated factor VIII. Emicizumab is used for the prevention and treatment of hemophilia A. It has been shown to be effective in the treatment of hemophilia A. It has been shown to be effective in the prevention and treatment of hemophilia A. |
Storage | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. |
Note | For research use only |
Expiration Date | 12 months from date of receipt. |
ELISA, FC | |
Human, Monkey | |
Monoclonal | |
Unconjugated |
ELISA, FA, FACS, Kinetics | |
Human | |
Monoclonal | |
Unconjugated |
Monoclonal | |
Unconjugated |